IP Group PLC Portfolio company funding leads to GBP36m gain (4614I)
December 02 2022 - 5:38AM
UK Regulatory
TIDMIPO
RNS Number : 4614I
IP Group PLC
02 December 2022
FOR RELEASE ON 02 December 2022
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO. 596/2014)
WHICH FORMS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION
(WITHDRAWAL) ACT 2018.
IP Group plc - Portfolio company funding round leads to GBP36m
net fair value gain
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which
develops world-changing science and technology businesses across
life sciences, technology and cleantech, notes that following the
completion of a first close of a funding round by a portfolio
company in its top twenty most valuable holdings, it has recorded a
net unrealised fair value gain of approximately GBP36m or
approximately 4p per share. The Group has committed GBP4.2m to the
funding round. Further information will be provided in due
course.
For more information, please contact:
IP Group plc www.ipgroupplc.com
+44 (0) 20 7444 0062/+44 (0)
Liz Vaughan-Adams, Communications 7967 312125
Charlotte Street Partners
David Gaffney +44 (0) 7854 609998
Andrew Wilson +44 (0) 7810 636995
Notes for editors
About IP Group
IP Group develops world-changing science and technology
businesses across life sciences, technology and cleantech (through
Kiko Ventures). The Group has a strong track record of success,
having been the founder investor in a number of high-profile
companies including Oxford Nanopore Technologies plc, and has one
of the most exciting portfolios of high-growth businesses in
Europe. The Group also owns Parkwalk, the UK's largest growth EIS
fund manager which backs world-changing technologies emerging from
the UK's leading universities and research institutions. IP Group
is listed on the Main Market of the London Stock Exchange under the
code IPO.
For more information, please visit our website at
www.ipgroupplc.com .
ENDS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCBBBDDLXGDGDD
(END) Dow Jones Newswires
December 02, 2022 06:38 ET (11:38 GMT)
Ip (LSE:IPO)
Historical Stock Chart
From Apr 2024 to May 2024
Ip (LSE:IPO)
Historical Stock Chart
From May 2023 to May 2024